BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with a dismal prognosis despite aggressive therapies. New approaches are needed for those with refractory disease. PBL expresses antigens similar to multiple myeloma (MM), including B-cell maturation antigen (BCMA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Raghunandan, Sharmila, Pauly, Melinda, Blum, William G, Qayed, Muna, Dhodapkar, Madhav V, Elkhalifa, Mohamed, Watkins, Benjamin, Schoettler, Michelle, Horwitz, Edwin, Parikh, Suhag, Chandrakasan, Shanmuganathan, Leung, Kathryn, Bryson, Elyse, Deeb, Laura, Kaufman, Jonathan L, Worthington-White, Diana, Alazraki, Adina, Schecter, Jordan M, Madduri, Deepu, Jackson, Carolyn C, Zudaire, Enrique, Taraseviciute-Morris, Agne, Babich, Alexander, Nesheiwat, Tonia, Vogel, Martin, Lendvai, Nikoletta, Pacaud, Lida, Williams, Kirsten M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163502/
https://www.ncbi.nlm.nih.gov/pubmed/37137553
http://dx.doi.org/10.1136/jitc-2023-006684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163502/
https://www.ncbi.nlm.nih.gov/pubmed/37137553
http://dx.doi.org/10.1136/jitc-2023-006684

Ejemplares similares